Helaina

We had a great interview with Nutritional Outlook at this years SupplySide West. Check out the video below and learn about effera™ human lactoferrin, a bioactive protein that uniquely supports gut health, women's health, and so much more. Discover why human-like proteins are shaping the future of nutrition with our CEO Laura Katz

What if the powerful nutrients in breast milk could transform health for all ages? In a recent conversation with Kate Adams from Startup Success our CEO and Founder, Laura Katz talks about how Helaina is using a revolutionary platform to replicate functional proteins found in the human body. Don't miss this podcast that highlights: 🔹 Hard-fought lessons from fundraising 🔹 The surprising challenges of being a solo biotech founder 🔹 Laura’s framework for turning vision into reality 🔹 The value of mentorship and building a supportive network

effera™ is the first human-equivalent lactoferrin ingredient on the market, supported by both pre-clinical and clinical studies. effera™ helps balance iron levels by binding and releasing iron where it is needed most, making it an ideal addition to health-focused products. Why is iron optimization so important? 🔹 Fuels women’s health across all life stages 🔹 Supports an active lifestyle and faster recovery 🔹 Promotes healthy aging. Ready to elevate your next product? Discover the unique benefits of effera™ below.

Helaina's first randomized double-blind controlled clinical study to measure the body’s immune response to effera™ recently published in The International Journal of Toxicology. The results of the study demonstrated: Participants taking effera™, at both a high (3.4 g/day) and low-dose (0.34 g/day), produced no increase in antibodies against the protein, suggesting tolerability of the ingredient. Participants taking bovine lactoferrin (3.4 g/day) produced an increase in antibodies against the protein, suggesting an immunogenic response against bovine lactoferrin. No reported adverse events in any supplemented groups and safety was supported in all blood measurements including iron biomarkers   The study is the first ever to assess the immune response against an orally ingested human protein as a food ingredient. This foundational research establishes the initial case for the superiority and benefit of using human proteins to transform nutrition. Use the link below to check out the study: https://lnkd.in/ekz3Phw5

We are so excited to be first time exhibitors at SupplySide West. Come by our booth #1631 to learn more about effera™️ human lactoferrin. We will have gummy and drink mix samples available.

We are so excited to see all our friends and collegues next week at SupplySide West. 📍 Visit us at Booth #1631 to learn about the benefits of effera™, the first human equivalent lactoferrin. 🔬Discover insights from effera’s™ latest clinical study. 💰Learn about Helaina's $45 million Series B funding to accelerate our commercialization efforts of effera™. 😋Come by the booth for exclusive samples of effera™ and experience its benefits firsthand. 🗓️Don’t miss out—use the link below to book an appointment with our team, or simply stop by Booth #1631 for a chat. https://lnkd.in/dNZEXNpm

PSA from Helaina's Recruiting Team: Many cybercriminals today are using fraudulent job posts and job offers to access personal information. To keep yourself safe, we have a few helpful recommendations: Beware of fraudulent job posts! All official Helaina jobs are posted on our careers site. If you view a job post that isn't listed on our job board (https://lnkd.in/eB6wcQne) or a job posting with a different URL, the post could be a scam. Lookout for fake recruiters! When interacting with a Helaina recruiter, ensure this individual has an official "@myhelaina.com" email address. We do not use any derivatives of this address, such as "@helainadr.com." If someone claims to contact you on behalf of Helaina using a non-Helaina email address, this is a red flag!

We’re thrilled to announce that Helaina has raised a $45 Series B to accelerate the commercialization of bioactive proteins starting with effera™ human lactoferrin. This infusion of new capital marks our next phase of growth and is the result of years of our dedicated team’s work to drive innovation and scientific rigor within nutrition. At this pivotal moment in our journey, we’re proud to partner with Avidity Partners, an investment firm with an outstanding reputation for supporting best-in-class biotech companies rooted in clinically-backed science. To learn more about what we’re building and our commercial launch, check out AgFunder’s piece. https://lnkd.in/erAtXXya

Check out Helaina's market first - effera™ in Nutraceuticals World Learn how effera™ is revolutionizing the functional food and supplement industry as the first-ever human equivalent lactoferrin for food and supplement applications. Clinically studied for safety, quality, and stability, effera™ brings unmatched benefits for immune health, gut function, and active nutrition. https://lnkd.in/ecAQxSqJ

We are headed to SupplySide West 🛩 next month and will be exhibiting for the first time. Use the link below to book a meeting 🗓 and learn about our groundbreaking ingredient effera™ - the first human equivalent lactoferrin available on the market, supported by pre-clinical and clinical studies. Lactoferrin is the most abundant protein found in colostrum which sequesters and delivers iron where it is needed most. effera™ is made from a precision fermentation process which replicates lactoferrin to ensure a highly bioavailable ingredient. Meet with us to learn how effera™ provides health benefits for gut and immune health, women's health, and active nutrition. https://lnkd.in/egqstidT